Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2013 Financial Results
Date:11/5/2013

ivate Securities Litigation Reform Act of 1995This press release contains forward-looking statements, including, but not limited to, statements related to Jazz Pharmaceuticals' future financial results, the company's growth strategy and potential, 2013 financial guidance and other statements that are not historical facts. These forward-looking statements are based on Jazz Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with maintaining and increasing sales of and revenue from Xyrem, such as the potential introduction of generic competition and changed or increased regulatory restrictions on or requirements with respect to Xyrem, as well as similar risks related to effectively commercializing the company's other marketed products, including Erwinaze and Prialt; protecting and expanding the company's intellectual property rights; obtaining appropriate pricing and reimbursement for the company's products in an increasingly challenging environment; ongoing regulation and oversight by U.S. and non-U.S. regulatory agencies; dependence on key customers and sole source suppliers, including the risk that the company may not be able to supply sufficient product to meet demand; the difficulty and uncertainty of pharmaceutical product development, including the timing thereof and the uncertainty of clinical success and regulatory approval; the company's ability to identify and acquire, in-license or develop additional products or product candidates to grow its business; and possible restrictions on the company's ability and flexibility to pursue certain future opportunities as a result of its substantial outstanding debt obligations; as well as risks related to future opportunities and plans, in
'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
2. Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio
3. Jazz Pharmaceuticals to Present at the 2013 Credit Suisse Healthcare Conference on November 12
4. Immune Pharmaceuticals Appoints Liquidity Provider to Facilitate Trading on NASDAQ OMX Stockholm Exchange
5. Actinium Pharmaceuticals to Host Corporate Update and Virtual Roadshow Conference Call on November 11
6. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
7. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
8. Merrimack Pharmaceuticals Announces Results From A Phase 2 Study Of MM-121 (SAR256212) In Combination With Paclitaxel In Patients With Platinum-Resistant Or Refractory Advanced Ovarian Cancers
9. Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
11. Cumberland Pharmaceuticals To Announce Third Quarter 2013 Financial Results On November 5, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , August 28, 2015 The scientific ... collaboration with one of the leading academics in the field ... world record holder in life extension for model animals - ... biology of aging and age-related diseases, primarily, around the stability ... has just been published as "Stability analysis of a model ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 Perrigo ... commented on the Mylan N.V. ("Mylan") (NASDAQ: MYL ... acquire Perrigo. "Our views of Mylan,s offer ... to be, based on our Board,s careful reflection of ... depend on the limited choices that Mylan has allowed ...
(Date:8/28/2015)... Denmark and ATLANTA ... 31, 2015 the US Food and Drug Administration (FDA) cleared ... Depressive Disorder in adult patients who have failed to receive ... TMS is a non-invasive technique for stimulating neural tissue in ... Major Depressive Disorder. The procedure has been proven safe and ...
Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
(Date:8/30/2015)... , ... August 31, 2015 , ... Avid collector Andrew ... the Doors Shrine Auditorium concert posters. This hand colored artwork is one of the ... in Los Angles. Hawley states, "When the doors played the Shrine, the band ...
(Date:8/30/2015)... ... August 31, 2015 , ... ... third of tax receipts, issues that are critically important to them are often ... attorneys and lobbyists monitoring proposed legislation and changing tax and regulatory policies. Smaller ...
(Date:8/30/2015)... ... August 31, 2015 , ... Intellitec ... Annual Convention & Expo October 5th & 6th in San Antonio, TX. Dedicated ... convention brings industry professionals from all over the country come to share the ...
(Date:8/30/2015)... ... August 31, 2015 , ... This month, top ... to help assisted living facilities and nursing homes protect their residents from neglect ... to security experts at the company, security systems don’t just protect; they also ...
(Date:8/30/2015)... ... August 30, 2015 , ... AvePoint, the established ... a Silver Sponsor of the Digital Workplace Conference, taking place Sunday, August 30 ... Throughout the event, AvePoint will showcase its file analysis, management, and migration solutions ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 3Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 4Health News:Intellitec Solutions to feature Microsoft Dynamics GP at AHCA/NCAL 66th Annual Convention & Expo 2Health News:Total Security Announces Security Systems Tips for New York Assisted Living Facilities and Nursing Homes 2Health News:Total Security Announces Security Systems Tips for New York Assisted Living Facilities and Nursing Homes 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4
... Oct. 17 Health and,disability insurance companies are systematically ... of practices by health and disability,insurers and their effect ... Insurers provide no healthcare goods or services. ... inflation.,Medical debt is the number one cause of personal ...
... ANGELES, Oct. 17 The California Science,Center,s Science Matters ... in a free program from 1 - 3:30 p.m. ... the current science of,fear, which fears are innate and ... how our collective anxieties are shaped by culture and ...
... Home Workers From Across the Nation Rally for,Improved Nursing ... caravan from Toledo, Ohio to,Washington, DC to highlight concerns ... Wash., DC rally set for Oct 22, TOLEDO, ... caregivers from across the nation, senior advocates and,elected leaders ...
... 17 Lornamead, Inc., a leading,provider of personal ... branding professionals to its growing operation. Patti,D,Agostino joins ... Karen,Murabito joins as Marketing Director, Skin Care. This ... appointments over the past four months,reflecting the firm,s ...
... PHOENIX, Oct. 17, 2007 Two Arizona-based philanthropic ... innovative initiative to develop personalized molecular diagnostics. The ... every persons unique physiological makeup is critical to ... the same time reducing medical costs. , ...
... This is just another example of the Bush Administration promoting, politics ... with, the oversight of the federal family planning program ... ... Oct. 17 The National Abortion,Federation (NAF) denounces the appointment of ...
Cached Medicine News:Health News:Practices in Health & Disability Insurance - The Lives & Wealth They Cost America 2Health News:Manor Care Shareholders Vote to Approve $6.3 Billion Carlyle Buyout 2Health News:Lornamead Grows With Addition of Two Branding Pros 2Health News:The Virginia G. Piper Charitable Trust and Flinn Foundation launch 2Health News:The Virginia G. Piper Charitable Trust and Flinn Foundation launch 3Health News:The Virginia G. Piper Charitable Trust and Flinn Foundation launch 4Health News:National Abortion Federation Denounces the Appointment of Dr. Orr to Oversee Federal Family Planning Funds 2
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... microprocessor controlled, Blanketrol II total ... provides effective patient warming and/or ... The Blanketrol II offers the ... rates of any hyper-hypothermia system ...
Medicine Products: